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Current estimates indicate that only
about 1.2% of the mammalian genome
codes for amino acids in proteins. How-
ever, mounting evidence over the past
decade has suggested that the vast major-
ity of the genome is transcribed, well
beyond the boundaries of known genes, a
phenomenon known as pervasive tran-
scription [1]. Challenging this view, an
article published in PLoS Biology by van
Bakel et al. concluded that ‘‘the genome is
not as pervasively transcribed as previous-
ly reported’’ [2] and that the majority of
the detected low-level transcription is due
to technical artefacts and/or background
biological noise. These conclusions attract-
ed considerable publicity [3–6]. Here, we
present an evaluation of the analysis and
conclusions of van Bakel et al. compared
to those of others and show that (1) the
existence of pervasive transcription is
supported by multiple independent tech-
niques; (2) re-analysis of the van Bakel et
al. tiling arrays shows that their results are
atypical compared to those of ENCODE
and lack independent validation; and (3)
the RNA sequencing dataset used by van
Bakel et al. suffered from insufficient
sequencing depth and poor transcript
assembly, compromising their ability to
detect the less abundant transcripts outside
of protein-coding genes. We conclude that
the totality of the evidence strongly
supports pervasive transcription of mam-
malian genomes, although the biological
significance of many novel coding and
noncoding transcripts remains to be ex-
plored.
Previous Evidence for Pervasive
Transcription
The conclusion that the mammalian
genome is pervasively transcribed (i.e.,
‘‘that the majority of its bases are associ-
ated with at least one primary transcript’’
[1]) was based on multiple lines of
evidence. Both large-scale cDNA sequenc-
ing and hybridization to genome-wide
tiling arrays were the major empirical
sources of data. Analysis of full-length
cDNAs from many tissues and develop-
mental stages in mouse showed that at
least 63% of the genome is transcribed and
identified thousands of novel protein-
coding transcripts and over 30,000 long
noncoding intronic, intergenic, and anti-
sense transcripts [7–9]. In parallel, whole
chromosome tiling array interrogation of
the RNA content of a variety of human
tissues and cell lines revealed that, collec-
tively, at least 93% of genomic bases are
transcribed in one cell type or another
[1,10–13].
Since it is well established that highly
expressed mRNAs dominate the non-
ribosomal portion of the polyA+ transcrip-
tome [7,8,10,14–19], normalization ap-
proaches were used to reduce the quantity
of highly expressed transcripts in these
cDNA analyses [7,8], and are implicit in
tiling array approaches. This was neces-
sary to allow the detection of rarer (often
cell type–restricted [1,13,16,19,20]) tran-
scripts.
The evidence for pervasive transcription
also includes observations from a wide
variety of other independent techniques
(see reviews [21] and [22] for references).
Indeed, a simple query of currently
available human spliced EST data in
GenBank shows that documented tran-
scripts cover 57.09% of the genome.
Because ESTs are largely generated from
polyadenylated RNAs and do not exhaus-
tively sample the transcriptome, this cov-
erage represents the lower bound of
genomic transcription.
Based on an analysis of genome-wide
tiling arrays and short read RNA sequenc-
ing data, van Bakel et al. report that ‘‘most
‘dark matter’ transcripts (i.e., novel tran-
scripts of unknown function) are associated
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with known genes’’ [2], a well-established
and uncontroversial conclusion that has
been reported previously [1,8,10,13,14,
19,23–25] (see Text S1). Controversially,
however, they also concluded that ‘‘the
genome is not as pervasively transcribed as
previously reported’’ [2]. The authors
suggested that the discrepancy is explained
by tiling arrays producing more false
positive signals than previously appreciat-
ed, although they do not reconcile their
conclusions with the extensive transcrip-
tome cataloged by cDNA analyses [7,8]
and other approaches [21,22]. The multi-
centre ENCODE pilot project, for exam-
ple, found that 74% of the bases in the
genome areas analyzed were covered by
primary transcripts identified by two
independent technologies [1].
Congruency of Tiling Array and
Short Read RNA Sequencing
Data
A major feature of van Bakel et al.’s
argument was based on their comparison
of precision recall (PR) curves generated
from tiling arrays and RNA sequencing
(RNA-seq), from which they concluded
that tiling array results suffer from high
false positive rates. These PR curves in
principle measure the order in which
transcribed regions are detected when
the expression detection threshold is
lowered in a stepwise manner. This
analysis performed by van Bakel et al.
indicated a large difference between tran-
scribed regions detected by tiling arrays
(referred to as transfrags or TARs since
they are most often parts of longer
transcripts) compared to those detected
by RNA-seq (seqfrags). They showed that
RNA-seq discovers known protein-coding
exons at higher thresholds compared to
unannotated transfrags, while tiling arrays
found a larger fraction of non-exonic
regions, even at high thresholds, from
which they conclude a lower accuracy of
tiling arrays.
There are two major limitations to this
analysis (see also Text S1). First, the
implication of lower accuracy of tiling
arrays is made in the absence of an
independent validation of the false positive
rate (which, by contrast, was routinely
conducted in previous tiling array studies
using techniques such as RT-PCR, see e.g.,
[10,13]). As explained later, correlating
individual tiling array probes and RNA
sequencing depth is not an appropriate
comparison and cannot substitute as a
validation method. Thus, the false-positive
claim by van Bakel et al. is impossible to test
precisely with the presented data.
Second, while RNA-seq offers linear
quantification over a wide range, tiling
arrays saturate at the upper end of signal
strength. As a consequence, arrays are less
reliable in distinguishing highly expressed
known exons from less highly expressed
novel transfrags, resulting in a lower
precision value for any given recall in the
PR curves. This fact explains much of the
difference in shape between the curves,
but does not imply that the regions
detected by either technology are false
positives, only that quantification by
arrays is less linear than by RNA-seq,
which is well understood.
We performed a similar PR curve
analysis using ENCODE tiling array data
for K562 cellular RNA, and found results
that are substantially different from those
reported by van Bakel et al., but consistent
with a recent analysis of a sample-matched
nematode RNA-seq and tiling array data-
set by Agarwal et al. (2010) [26]. Briefly,
we identified transfrags on the tiling arrays
with a range of different thresholds.
Similar to the analysis by van Bakel
et al., every transfrag that overlapped
any annotated exon was scored as positive,
while all others were scored negative. The
resulting PR curve was dramatically dif-
ferent from the curve presented in
Figure 1A of van Bakel et al. Moreover,
the shape of the PR curve and the
precision for any given recall level for
our tiling arrays is much closer to the van
Bakel et al. sequencing data and to our
own sequencing data from a matched
K562 sample (Figures 1 and S1). These
results suggest that, while decreased dy-
namic range of tiling arrays leads to an
increased number of non-exonic regions
being detected at high thresholds (lower
initial precision values; see Figure 1), the
difference between sequencing and tiling
arrays is not large and the discrepancies
identified by van Bakel et al. appear to be
specific to their analysis.
A second argument for lower accuracy
of tiling arrays by van Bakel et al. was
based on the observation that there is a
relatively low correlation between individ-
ual probe-level signals from arrays and
sequencing read depth. Unfortunately,
such a statement reveals a fundamental
lack of understanding of tiling array
technology. Tiling arrays are neither
intended nor designed to give reliable
signals from each individual probe. The
more appropriate analysis for correlation
is at the level of transcribed regions such as
exons or transfrags, as has been done
previously [26] and which generally shows
a good correlation. This also points to
another problem in the van Bakel et al.
study, which used tiling arrays with 36-bp
spaced probes, offering only very few
probes for each exon. The 5-bp spaced
(7X resolution) arrays used for ENCODE
(and in many published human transcrip-
tome studies) offer more power to filter
individual probe-level noise (Figures S2,
S3, and S4). Overall it appears that, while
RNA-seq offers better linearity of quanti-
fication and much higher resolution for
boundaries of transcribed regions, the
overall detection accuracy of tiling arrays
is not significantly lower. This is also in
agreement with the recent analysis by
Agarwal et al. [26], which consistently
observed intergenic and intronic transcrip-
tion.
Finally, it is difficult to reconcile the
purported high false positive nature of the
tiling array results with numerous previous
studies that validated up to 94% identified
transcripts using independent techniques
such as RT-PCR, RACE, and Northern
blot analyses [10–13,27].
Detection and Interpretation of
Low-Level Transcription
We suggest that the overarching con-
clusions drawn by van Bakel et al.—that
there is only spasmodic (not pervasive)
low-level transcription of much of the
genome, and that much of this transcrip-
tion has ‘‘random character’’ [2]—are the
result of a number of debatable aspects of
their logic and analysis. These may be
summarized as (1) insufficient sequencing
depth and breadth and poor transcript
assembly, together with the sampling
problems that arise as a consequence of
the domination of sequence data by highly
expressed transcripts; compounded by (2)
the dismissal of transcripts derived from
introns; (3) a lack of consideration of non-
polyadenylated transcripts; (4) an inability
to discriminate antisense transcripts; and
(5) the questionable assertion that rarer
RNAs are not genuine and/or functional
transcripts.
1. Sequencing depth, breadth, and assembly.
The conclusions of van Bakel et al. about
the pervasiveness of transcription were
based on transcript read number, not the
extent of genomic coverage of the observed
transcripts (which is the correct metric),
stating ‘‘the vast majority of sequence reads
in polyA+ samples correspond to known
genes and transcripts, arguing against
widespread transcription to the extent
reported previously’’. The former fact does
not justify the consequential argument.
This also highlights a key caveat of RNA
sequencing—i.e., diminishing returns—
whereby abundant transcripts constitute
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the majority of reads, making rare tran-
scripts difficult to find in the absence of
normalization approaches. This problem is
clearly evidenced in the van Bakel et al.
dataset, where ,88% of unique polyA+
sequences mapped to exons of known
genes, which comprise just over 2% of the
genome. Therefore, the transcription in the
remainder of the genome was sampled by
only ,12% of the reads.
This insufficient depth of sequencing is
illustrated by comparing the rates of
discovery for exonic, intronic, and inter-
genic sequences as sequencing depth
increases. Despite continuing to constitute
most reads, the area covered by exons
quickly moves towards saturation, while
the area covered by intronic and interge-
nic transcripts was found to ‘‘keep increas-
ing at roughly constant rates’’ [2]. Thus,
the sequence coverage of the vast majority
of the genome is not saturated, and
potentially includes many novel protein-
coding and noncoding transcripts insuffi-
ciently sampled at the given read depth.
Underscoring the importance of ade-
quate transcriptome sampling, concurrent-
ly published deep sequencing studies, with
two to three times greater depth of data
from polyA+ RNAs from cultured cells,
were still not saturating [16,28]. Nonethe-
less, and unsurprisingly, the increased
sequencing depth led to increased novel
transcript discovery, as only 70% of the
identified splice junctions were derived
from ‘‘known genes’’ in a mouse myoblast
cell line [28], compared to 94% reported by
van Bakel et al. Re-analysis of transcript
assembly at different sequencing depths
also suggested, crucially, poor assembly and
poor recovery of lowly expressed transcripts
at the deepest level of sequencing used by
van Bakel et al. [28].
The lack of sequencing depth in the van
Bakel et al. study was exacerbated by the
pooling of 10 tissues/cell lines and the use
of such a highly complex tissue as brain.
Increasing the complexity of the sample
dilutes the relative proportion of tissue-
and cell type–specific transcripts. Using
the brain (170 billion cells) [29], we
calculate that a cell type–specific transcript
present at ,10 copies per cell (a common
level of abundance) in 0.1% of cells would
have only a ,50% chance of being
detected by any reads at the depth of
sequencing utilized by van Bakel et al., let
alone of being assembled into a complete
transcript (see Text S1).
Importantly, because the genomic
strand from which individual sequence
reads were derived was unknown in their
study, the method that van Bakel et al.
employed to assemble these reads into
transcriptional units required that contigs
in the vicinity of known genes be bounded
by splice sites or cross a splice site,
automatically excluding (i) nearly all 59
and 39 UTRs; (ii) deep sequencing reads,
other than the splice site, in genes with a
single intron (Figure 2); (iii) transcripts
from single exon genes, such as the highly
expressed metastasis associated lung ade-
nocarcinoma transcript 1 (MALAT1) (Fig-
ure S5), and transcripts (not containing a
splice site) originating from introns [30];
and (iv) perhaps most importantly, any
known transcript for which there was no
identifiable splice junction in the dataset.
This methodology therefore discriminates
against lowly expressed transcripts, heavily
biasing in favor of common mRNAs.
2. Intronic transcripts. Despite the data
showing that 51.4% of the genomic area
Figure 1. Precision recall curves for the overlap of transcribed regions (transfrags) detected in different experiments and
annotated exons (from GENCODE version 4 and the UCSC known genes track from the UCSC Genome Browser). The Clark et al.
transfrags are based on data generated as part of the ENCODE transcriptome project from K562 cell polyA+ RNA. The transfrags are generated from
5-bp two-color tiling arrays (MinRun = 40 bp, MaxGap = 40 bp). The seqfrags are based on 200 million paired-end 76 bp reads generated on the
Illumina sequencing platform. Any detected region that overlaps an annotated exon is scored positive, all others negative. Fewer exons are detected
overall (compared to van Bakel et al. [2]), likely reflecting the difference between a relatively homogeneous cell line and complex tissue like brain.
doi:10.1371/journal.pbio.1000625.g001
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covered by their human reads aligns with
intronic regions, van Bakel et al. presump-
tively dismissed these sequences as mainly
derived from unprocessed pre-mRNAs,
due to their ‘‘low coverage and ubiquitous
character’’. Intronic regions, which corre-
spond to more than a third of the genome,
are by definition transcribed, and hence
must be included in estimates of the
amount of transcription across the ge-
nome. It is also important to note that
many introns are not fixed entities and
whether a genomic region is intronic,
intergenic, or exonic depends on the cell
type and physiological state of the cell. In
addition, the number of functional RNAs
that may be derived from introns is
unknown, although there is considerable
evidence that they can produce a diversity
of discrete stable RNA products from both
the sense and antisense strands [12,15,31,
32–34], including novel RNAs with vali-
dated functions (e.g., [35]).
3. Non-polyadenylated RNAs. The data
used by van Bakel et al. to support the
conclusion that ‘‘dark matter transcripts
make up a small fraction of the total
sequenced transcript mass’’ focused on
polyadenylated RNA. However, previous
transcriptomic analyses showed that over
40% of non-ribosomal transcripts are non-
polyadenylated [13], and more recent deep
sequencing of total RNA has revealed that
over 45% of uniquely mapping sequence
reads originate from intronic and intergenic
regions [36,37], compared to only 10% in
the polyA+ RNA from equivalent samples
examined by van Bakel et al.
4. Antisense and overlapping transcription.
Tiling array, cDNA, EST, and RNA se-
quencing evidence all indicate that consider-
able interleaved transcription occurs on both
strands [1,9,23,36], with at least 66% of all
protein-coding genes in mouse showing
evidence of overlapping or antisense tran-
scription [9]. However, van Bakel et al.
concluded that their data ‘‘argue against
widespread interleaved transcription of pro-
tein-coding genes’’. This discrepancy can be
explained in large part by the lack of strand
information in the RNA sequencing data
used by them to assemble transcriptional
units (TUs). Indeed, the assembled TUs
covered less than 26% of the genome
(compared to over 40% spanned by RefSeq
genes) and, tellingly, less than 2% of RefSeq
annotated 39UTR sequences. This lack of
coverage and strand information resulted in a
large underestimate of the extent of antisense
and overlapping transcription (Figures S6
and S7), for which functional evidence is also
emerging (see e.g., [38]).
5. Discriminating low signal strength from
background noise. The assertion of van Bakel
et al. that low sequence coverage (by
seqfrags) equates with transcriptional ‘‘by-
products’’ and/or ‘‘random initiation
events’’ is highly debatable. Such seqfrags
might equally, if not more, plausibly reflect
stochastic sampling of transcripts that are
less expressed, less stable, and more cell
specific [39]. This is not proof or even
evidence of irrelevance. Moreover, van
Bakel et al. infer non-functionality of rare
transcripts without any biological data, but
one cannot expect vast numbers of novel
coding and noncoding RNAs to be func-
tionally annotated coincident with their
discovery, especially if, as is likely, they have
many different functions [40]. The yeast
GAL10-ncRNA provides a good example:
despite a steady-state expression level of
around one transcript per 14 cells, it is
functional [41]. Similarly, the mammalian
HOTTIP RNA plays an important role in
epigenetic regulation despite an average
expression level of around 0.3 transcripts
per cell in expressing tissues [42]. There-
fore, while expression levels are important,
it cannot be assumed a priori that low
expression equates to non-functionality.
Summary
A close examination of the issues and
conclusions raised by van Bakel et al.
Figure 2. Poor coverage of single intron transcriptional units (TUs) by van Bakel et al. [2]. The figure shows the abundance of sequence
reads mapped to the HAR1A locus [43] (green) and the TU created from these tags by van Bakel et al. using TopHat (red) [44]. In contrast, the Clark
et al. TU created by reanalysis of sequence reads using Cufflinks [28] includes the extended 59 and 39 exonic sequences (dark blue).
doi:10.1371/journal.pbio.1000625.g002
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reveals the need for several corrections.
First, their results are atypical and gener-
ate PR curves that are not observed with
other reported tiling array data sets.
Second, characterization of the transcrip-
tomes of specific cell/tissue types using
limited sampling approaches results in a
limited and skewed view of the complexity
of the transcriptome. Third, any estimate
of the pervasiveness of transcription re-
quires inclusion of all data sources, and
less than exhaustive analyses can only
provide lower bounds for transcriptional
complexity. Although van Bakel et al. did
not venture an estimate of the proportion
of the genome expressed as primary
transcripts, we agree with them that
‘‘given sufficient sequencing depth the
whole genome may appear as transcripts’’
[2].
There is already a wide and rapidly
expanding body of literature demonstrat-
ing intricate and dynamic transcript ex-
pression patterns, evolutionary conserva-
tion of promoters, transcript sequences
and splice sites, and functional roles of
‘‘dark matter’’ transcripts [39]. In any
case, the fact that their expression can be
detected by independent techniques dem-
onstrates their existence and the reality of
the pervasive transcription of the genome.
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